Rocket Pharmaceuticals, Inc.
DE ˙ DB ˙ US77313F1066
2,44 € 0,00 (0,00%)
2026-06-04
AKTIENPREIS
SecurityDE:9IP1 / Rocket Pharmaceuticals, Inc.
InstitutionFmr Llc
Latest Disclosed Ownership462,630 shares
Latest Disclosed Value $ 1,656,218
Fmr Llc reports 17.04% increase in ownership of 9IP1 / Rocket Pharmaceuticals, Inc.

On May 15, 2026 - Fmr Llc filed a 13F-HR form disclosing ownership of 462,630 shares of Rocket Pharmaceuticals, Inc. (DE:9IP1) valued at $1,302,303 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 395,275 shares of Rocket Pharmaceuticals, Inc.. This represents a change in shares of 17.04% during the quarter. The current value of the position is $1,128,817 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 462,630 67,355 17.04 1,656 19.39 0.0000
2026-02-17 2025-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 395,275 83,574 26.81 1,387 36.52 0.0001
2025-11-13 2025-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 311,701 45,652 17.16 1,016 56.07 0.0001
2025-08-14 2025-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 266,049 220,494 484.02 652 114.85 0.0000
2025-05-12 2025-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 45,555 -83,979 -64.83 304 -81.39 0.0000
2025-02-13 2024-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 129,534 -335,922 -72.17 1,628 -81.06 0.0001
2024-11-13 2024-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 465,456 -113,823 -19.65 8,597 -31.07 0.0005
2024-08-13 2024-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 579,279 2,612 0.45 12,472 -19.72 0.0008
2024-05-13 2024-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 576,667 47,171 8.91 15,535 -2.10 0.0010
2024-02-13 2023-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 529,496 186,797 54.51 15,869 126.01 0.0012
2023-11-13 2023-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 342,699 74,431 27.75 7,022 31.73 0.0006
2023-08-11 2023-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 268,268 35,037 15.02 5,330 33.42 0.0004
2023-08-11 2023-03-31 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 233,231 -25,929 -10.01 3,995 -21.22 0.0004
2023-05-11 2023-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 233,231 -25,929 3,995 0.0004
2023-02-13 2022-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 259,160 7 0.00 5,072 22.61 0.0005
2022-11-10 2022-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 259,153 32,554 14.37 4,136 32.65 0.0004
2022-08-12 2022-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 226,599 -45,065 -16.59 3,118 -27.64 0.0003
2022-05-13 2022-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 271,664 -157,460 -36.69 4,309 -54.00 0.0003
2022-02-14 2021-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 429,124 -17,094 -3.83 9,368 -29.76 0.0007
2022-02-14 2021-09-30 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 446,218 -112,618 -20.15 13,337 -46.12 0.0011
2021-11-15 2021-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 446,218 -112,618 13,337 0.0002
2021-08-13 2021-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 558,836 -184,600 -24.83 24,751 -24.97 0.0019
2021-05-14 2021-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 743,436 -83,200 -10.06 32,986 -27.24 0.0028
2021-02-08 2020-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 826,636 15,300 1.89 45,333 144.42 0.0040
2020-11-13 2020-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 811,336 -189,443 -18.93 18,547 -11.45 0.0019
2020-08-24 2020-06-30 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 1,000,779 -148,808 -12.94 20,946 30.61 0.0023
2020-08-13 2020-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 1,000,779 -148,808 20,946 514.5819
2020-05-14 2020-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,149,587 -124,000 -9.74 16,037 -44.68 0.0022
2020-02-07 2019-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,273,587 -86,200 -6.34 28,987 82.98 0.0032
2019-11-13 2019-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 1,359,787 0 0.00 15,842 -22.33 0.0019
2019-08-13 2019-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 1,359,787 -105,312 -7.19 20,397 -20.62 0.0024
2019-05-13 2019-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,465,099 0 0.00 25,697 18.35 0.0031
2019-02-13 2018-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 1,465,099 392,900 36.64 21,713 -17.75 0.0030
2018-11-09 2018-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 1,072,199 1,072,199 26,398 0.0030
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.